
AI safety legislation has a conflict-of-interest problem — Big US labs are warning of risk just as cheaper Chinese open-weight models erode their commercial edge
OpenAI supports bipartisan push in U.S. Congress to restrict China's access to advanced AI accelerators, raising questions about genuine safety concerns versus commercial protectionism.
The battle for AI dominance continues as major US tech companies advocate for stricter export controls on advanced AI technology to China. OpenAI has reportedly joined a bipartisan congressional effort to restrict China's access to AI accelerators and equipment, citing safety concerns.
Safety improvements
OpenAI's latest model, GPT-6 Astra launched in September, demonstrates significant safety improvements. Internal testing showed the proportion of misaligned outcomes dropped dramatically from 18.8% with GPT-5.6 Sol to just 3.4% with Astra in computer-use safety benchmarks.
Commercial concerns
The battle for AI models and export controls continues amidst a Jensen Huang-free Nvidia. But who controls the flow of chips also controls the flow of leading frontier AI models.
However, experts question whether these safety concerns are genuine or a strategic move to protect market position. As cheaper Chinese open-weight models emerge, US labs face increasing pressure to maintain their competitive edge in the rapidly evolving AI industry.